ReviewFrontiers in aging neuroscience2026
Myofascial pain in older adults: a geroscience-informed framework integrating precision geriatrics and digital therapeutics.
Review in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myofascial pain syndrome (MPS) in the elderly is a significant contributor to chronic pain and functional decline, driven by a unique set of age-related pathophysiological challenges. Core geroscience principles-including sarcopenia, inflammaging, and cellular senescence-converge to create a state of heightened central sensitization that amplifies pain. Traditional pharmacotherapy is fraught with risks in this population due to polypharmacy and vulnerability to adverse effects, with many common analgesics discouraged by geriatric guidelines. This review proposes an innovative biopsychosocial framework integrating precision geriatrics and digital therapeutics to address these challenges. Precision geriatrics employs multidimensional assessment tools (e.g., ultrasonography, frailty indices) to phenotype patients and tailor interventions, while digital therapeutics deliver evidence-based non-pharmacological interventions like cognitive behavioral therapy and therapeutic exercise, overcoming access barriers. The proposed framework prioritizes non-pharmacological strategies, advocates for structured deprescribing, and emphasizes geriatrically-adapted interventions delivered through multidisciplinary teams. By synthesizing recent evidence, this review provides a comprehensive roadmap for clinicians to move beyond a one-size-fits-all approach, offering safer, more effective care that improves function, independence, and quality of life for older adults with MPS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.